Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183–94.Web of ScienceCrossrefPubMedGoogle Scholar
Madhra M, Fraser IS, Munro MG, Critchley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand 2014;93:619–25.Web of SciencePubMedCrossrefGoogle Scholar
Romm A. Botanical medicine for women’s health. St Louis, Mo: Churchill Livingstone/Elsevier, 2010.Google Scholar
Donald J, Brown N. Vitexclinical monograph. Med Ser 1994;45:132–7.Google Scholar
Zamani M, Mansour GM, Farimani M, Nasr ES. Efficacy of mefenamic acid and Vitex in reduction of menstrual blood loss and HB changes in patients with a complaint of menorrhagia. Iran J Obstet Gynecol Infertil 2007;10:79–86.Google Scholar
Daniele C, Coon JT, Pittler MH, Ernst E. Vitexcastus. Drug Saf 2005;28:319–32.Google Scholar
Shahhosseini Z, Amin G, Danesh M, Abedian K. Double blind study of anti primary dysmenorrhea effects of vitagnus. J Mazandaran Univ Med Sci 2005;15:15–21.Google Scholar
Shobeiri F, Zeraati F, Mansouri Z, Araghchian M, Nazari M. The comparative effect of herbal extract of vitagnus and mefenamic acid on primary dysmenorrhea. Zahedan J Res Med Sci 2012;14:30–3.Google Scholar
Schulz V, Hänsel R, Tyler VE. The 100 most commonly prescribed herbal medications in Germany. In: Rational phytotherapy. Springer, Berlin, Heidelberg: Springer, 1998:287–92.Google Scholar
Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, et al. Vitexcastus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 1993;43:752–6.PubMedGoogle Scholar
Shobeiri F, Zeraati F, Araghchian M, Nazari M. The effect of fennelin, vitagnus and mefenamic acid in the treatment of menstrual bleeding. Sci J Hamadan Univ Med Sci 2014;21:171–6.Google Scholar
Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Ahmadpour P, Javadzadeh Y. Effects of Vitexand Flaxseed on cyclic mastalgia: a randomized controlled trial. Complement Ther Med 2016;24:90–5.CrossrefPubMedGoogle Scholar
van Die MD, Burger HG, Bone KM, Cohen MM, Teede HJ. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause 2009;16:156–63.Web of ScienceCrossrefPubMedGoogle Scholar
Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitexcastus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Women’s Mental Health 2017;20:713–19.CrossrefGoogle Scholar
Maleki-Saghooni N, Karimi FZ, Moghadam ZB, Najmabadi KM. The effectiveness and safety of Iranian herbal medicines for treatment of premenstrual syndrome: A systematic review. Avicenna J Phytomedicine 2018;8:96.Google Scholar
Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of Vitexcastus: a systematic review and meta-analysis. Am J Obstet Gynecol 2017;217:150–66.CrossrefPubMedGoogle Scholar
van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med 2013;79:562–75.Web of SciencePubMedGoogle Scholar
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. United Kingdom, England: John Wiley & Sons, 2011.Google Scholar
Mirghafourvand M, Mohammad Alizadeh charandabi S, Javadzadeh Y, Ahmadpour P. The effect of Vitexand flaxseed on the menstrual bleeding: a randomized controlled trial. ZUMS J 2015;23:1–12.Google Scholar
About the article
Published Online: 2019-07-31
There was no financial support source for this study.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Ethical statement: Primary data for human nor for animals were not collected for this research work.